首页> 外文OA文献 >Characterizing the Tumor Immune Microenvironment (TIME) in Hepatocellular Carcinoma (HCC) And An Exploration Of The Prognostic Implications Of TIME Phenotypes On Treatment Response And Survival

【2h】

Characterizing the Tumor Immune Microenvironment (TIME) in Hepatocellular Carcinoma (HCC) And An Exploration Of The Prognostic Implications Of TIME Phenotypes On Treatment Response And Survival

机译：肝细胞癌（HCC）中肿瘤免疫微环境（时间）的特征及时间表型对治疗反应和生存的预后意义探讨

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M. Farha; I. El Naqa;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 基于单细胞技术的免疫微环境分析在肿瘤预后预测和免疫治疗中的研究进展 [J] . Tong Wu, Xuan Wu, Hong-Yang Wang, 癌症（英文版） . 2019,第011期
2. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. [J] . Toyoda H, Kumada T, Kaneoka Y, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2008,第2期

机译：肝细胞癌的肿瘤标志物预处理水平对肝癌患者治愈后生存的预后价值。
3. mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) [J] . PrajapatiH.J., SpiveyJ.R., HanishS.I., Annals of oncology: official journal of the European Society for Medical Oncology . 2013,第4期

机译：对比增强动态MRI在早期时间点的mRECIST和EASL反应可预测阿霉素药物洗脱珠经动脉化学栓塞（DEB TACE）治疗的不可切除肝细胞癌（HCC）患者的生存
4. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma [J] . Yang Bai, Haiping Lin, Jiaqi Chen, Frontiers in Molecular Biosciences . 2021,第a期

机译：鉴定肝细胞癌肿瘤免疫微环境中预后糖酵解相关的LNCrNA签名
5. Histotripsy for Non-Invasive Ablation of Hepatocellular Carcinoma (HCC) Tumor in a Subcutaneous Xenograft Murine Model [C] . Tejaswi Worlikar, Eli Vlaisavljevich, Tyler Gerhardson, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018

机译：皮下异种移植小鼠模型中非侵入性消融肝细胞癌（HCC）肿瘤的组织学。
6. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
7. RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma and is a prognostic factor for better survival [O] . Zhao-Ru Dong, Zhi-Qiang Chen, Xiao-Yun Yang, 2021

机译：RECK表达与肝细胞癌中的血管生成和免疫原性肿瘤微环境相关联是更好存活的预后因素
8. Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses [O] . Xingxing Gao, Hechen Huang, Yubo Wang, 2021

机译：肝细胞癌中的肿瘤免疫微环境表征鉴定了四个预后和免疫治疗相关的亚类

Characterizing the Tumor Immune Microenvironment (TIME) in Hepatocellular Carcinoma (HCC) And An Exploration Of The Prognostic Implications Of TIME Phenotypes On Treatment Response And Survival

著录项

引文网络

相似文献

相关主题

期刊订阅